BioCentury
ARTICLE | Company News

Par Pharmaceutical, Valeant sales and marketing update

November 6, 2006 8:00 AM UTC

VRX ended an October 2005 deal for PRX to promote VRX's Cesamet nabilone oral capsules in the U.S. (see BioCentury, Nov. 7, 2005). The cannabinoid agonist is approved to treat nausea and vomiting ass...